World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
90
Citations
33708
World Ranking
12113
National Ranking
6215

Research.com Recognitions

  • 1933 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

H. Ralph Schumacher is affiliated with the University of Pennsylvania in the United States. The scientist's work spans multiple areas in academic research, although specific details on fields of study, subfields, and main topics have not been documented in the available data.

There are no records of recent papers, frequent co-authors, or publication venues listed, which limits the ability to present a detailed account of their research output or collaborative networks. Similarly, information regarding book publications is not available.

Among the notable recognitions, H. Ralph Schumacher was awarded the title of Fellow of the American Association for the Advancement of Science (AAAS) in 1933. This fellowship is a designation that acknowledges contributions to the advancement of science.

This profile refrains from subjective interpretation and focuses solely on verifiable details concerning the scientist's affiliation and known distinctions.

Best Publications

  • Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis

    Daniel O. Clegg;Domenic J. Reda;Crystal L. Harris;Marguerite A. Klein

  • 2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia

    Dinesh Khanna;John D. FitzGerald;Puja P. Khanna;Sangmee Bae

  • Febuxostat compared with allopurinol in patients with hyperuricemia and gout

    Michael A. Becker;H. Ralph Schumacher;Robert L. Wortmann;Patricia A. MacDonald

  • 2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis.

    Dinesh Khanna;Puja P. Khanna;John D. FitzGerald;Manjit K. Singh

  • Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.

    H. Ralph Schumacher;H. Ralph Schumacher;Michael A. Becker;Robert L. Wortmann;Patricia A. MacDonald

  • Gout epidemiology: results from the UK General Practice Research Database, 1990-1999.

    Ted R Mikuls;J. T. Farrar;W. B. Bilker;S. Fernandes

  • The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial

    Michael A Becker;H Ralph Schumacher;Luis R Espinoza;Alvin F Wells

  • Serum uric acid and cardiovascular disease: Recent developments, and where do they leave us?

    Joshua F. Baker;Eswar Krishnan;Lan Chen;H. Ralph Schumacher

  • Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A department of veterans affairs cooperative study

    Daniel O. Clegg;Domenic J. Reda;Edwin Mejias;Grant W. Cannon

  • Gout and the risk of acute myocardial infarction.

    Eswar Krishnan;Joshua F. Baker;Daniel E. Furst;H. Ralph Schumacher

  • Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset.

    Raphaela Goldbach-Mansky;Jennifer Lee;Angela McCoy;Joseph Hoxworth

  • Hyperuricemia and Incidence of Hypertension Among Men Without Metabolic Syndrome

    Eswar Krishnan;C. Kent Kwoh;H. Ralph Schumacher;Lewis Kuller

  • Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions

    Naomi Schlesinger;Rieke E Alten;Thomas Bardin;H Ralph Schumacher

  • The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study

    R Terkeltaub;J S Sundy;H R Schumacher;F Murphy

  • A LITERATURE REVIEW OF THE EPIDEMIOLOGY AND TREATMENT OF ACUTE GOUT

    Karissa Y. Kim;H. Ralph Schumacher;H. Ralph Schumacher;Elke Hunsche;Albert I. Wertheimer

  • Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis

    H Ralph Schumacher;Judith A Boice;David I Daikh;Saurabh Mukhopadhyay

  • Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: A twenty-eight–day, multicenter, phase II, randomized, double-blind, placebo-controlled, dose-response clinical trial examining safety and efficacy in patients with gout

    Michael A. Becker;H. Ralph Schumacher;Robert L. Wortmann;Patricia A. MacDonald

  • Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with gout.

    Michael A Becker;H Ralph Schumacher;Patricia A MacDonald;Eric Lloyd

  • Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study

    H. R. Schumacher;M. A. Becker;E. Lloyd;P. A. MacDonald

  • Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. A department of veterans affairs cooperative study

    Daniel O. Clegg;Domenic J. Reda;Michael H. Weisman;Warren D. Blackburn

Frequent Co-Authors

Tuhina Neogi
Tuhina Neogi Boston University
Jasvinder A. Singh
Jasvinder A. Singh Veterans Health Administration
Nicola Dalbeth
Nicola Dalbeth University of Auckland
Michael Becker
Michael Becker University of Chicago
Robert Terkeltaub
Robert Terkeltaub University of California, San Diego
Kenneth G. Saag
Kenneth G. Saag University of Alabama at Birmingham
Hani El-Gabalawy
Hani El-Gabalawy University of Manitoba
Daniel E. Furst
Daniel E. Furst University of California, Los Angeles
Hyon K. Choi
Hyon K. Choi Harvard Medical School
William V. Williams
William V. Williams GlaxoSmithKline (United Kingdom)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring career options in healthcare extends beyond the traditional path of medical school. Many students consider flexible education alternatives such as the rn to bsn online programs, which allow registered nurses to advance their qualifications while continuing to work.

For those with a non-nursing background, direct entry msn programs for non nurses online provide a fast-track into advanced nursing roles without requiring a prior degree in nursing.

Prospective students seeking a straightforward entry into nursing may want to look at direct admit nursing programs, which simplify the application process and can offer clearer admission routes.

Alternatively, for those interested in the administrative side of healthcare, becoming a certified medical biller or coder is an excellent option. There are medical billing and coding schools that accept fafsa, making this pathway both accessible and affordable.

Each of these online pathways opens up new possibilities for a rewarding career in healthcare, providing flexibility, diverse opportunities, and accessible education options.

Best Scientists Citing H. Ralph Schumacher

Trending Scientists

Recently Published Articles